结论肝硬化患者Hp感染率高可能是引起高血氨症的重要原因。
Conclusions HP high infective rate in the patient with cirrhosis may be mainly cause of the hyperammonaermia.
同时还批准该药物作为NAGS缺乏所致慢性高氨血症的维持治疗药物。
The drug is also approved for use as maintenance therapy for chronic hyperammonemia that results from NAGS deficiency.
对并发症的预防：在间发性的感染中应有医疗注意防止高血氨。
Prevention of secondary complications: medical attention during intercurrent infections to prevent hyperammonemia .
结论结肠灌注透析治疗对失代偿性肝硬化顽固性腹水及内毒素血症、高氨血症、低钠血症均有较好的近期疗效。
Conclusion Colon perfusion dialysis therapy had good short-term effect on the decompensated hepatocirrhosis with intractable ascites, endotoxemia, hyperammonemia and hyponatremia.
目的研究结肠灌注透析对失代偿性肝硬化顽固性腹水及内毒素血症、高氨血症、低钠血症的治疗效果。
Objective to study the curative effect of the colon perfusion dialysis for the decompensated hepatocirrhosis with intractable ascites, endotoxemia, hyperammonemia and hyponatremia.
一旦诊断为高氨血症，应早期干预，降低病死率及减少后遗症的发生，并定期复查血氨水平来判断患儿的预后。
Once diagnosis neonatal hyperammonemia, should interfere to decrease mortality and complication, and detect plasma amino regularity to judge prognosis.
一旦诊断为高氨血症，应早期干预，降低病死率及减少后遗症的发生，并定期复查血氨水平来判断患儿的预后。
Once diagnosis neonatal hyperammonemia, should interfere to decrease mortality and complication, and detect plasma amino regularity to judge prognosis.
应用推荐